Editor’s Picks
BioSig Technologies Announces Workforce Reduction – Stock Falls
BioSig Technologies, a prominent player in the medical technology industry, made headlines today with its announcement of a significant reduction in its workforce and a...
Enovix Corp Achieves Record Q4 Revenue, Yet Stock Dips
Enovix Corporation (ENVX) has emerged as a significant player in the advanced silicon battery industry, renowned for its high-performance batteries catering to electric vehicles and...
BofA Downgrade Triggers Bloom Energy Stock Decline
Bloom Energy Corporation (BE) has been facing turbulent times, with a recent revenue miss and a subsequent decline in stock value. The departure of the...
Market Opens with Slight Declines Across Major Indices
Today’s market opening is shadowed by anticipation and apprehension as we await pivotal events that could sway the trajectory of stocks. US markets are starting...
Navigating NVIDIA’s Q4 Earnings – What to Expect?
NVDA Q4 2023 earnings analysis – As NVIDIA Corporation (NVDA) prepares to unveil its fourth-quarter results on February 21, 2024, the market is abuzz with...
Illuminating Enovix Corporation (ENVX): Q4 2023 Financial Results and Market Dynamics
Enovix Corporation Q4 2023 financial results – In the ever-evolving landscape of Enovix Corporation (ENVX), recent financial results and market movements offer a glimpse into...
Biofrontera Secures $16M Funding in Private Placement, Shares Surge
Biofrontera Inc, a leading figure in the biopharmaceutical sector specializing in dermatologic products, has garnered substantial attention in the market after unveiling a private placement...
AgriFORCE Growing Systems Stock Surges Over 100% on Patent Grant
In a remarkable turn of events, AgriFORCE Growing Systems Ltd. witnessed a notable surge in its stock value following the announcement of a significant patent...
Summit Therapeutics Plummets 27% Following Disappointing Q4 Results
Summit Therapeutics faced a tumultuous start to the trading week as investors reacted to the company’s Q4Â financial results, released on Tuesday morning. The stock...
Rapt Therapeutics Plunges to Record Low as FDA Halts Trials Over Liver Failure Concerns
In a blow to Rapt Therapeutics, the US Food and Drug Administration (FDA) has imposed a hold on two mid-stage trials of the company’s promising...
